
Methodology: Every two weeks we collect most relevant posts on LinkedIn for selected topics and create an overall summary only based on these posts. If you´re interested in the single posts behind, you can find them here: https://linktr.ee/thomasallgeyer. Have a great read!
On workflow impact and clinical proof, not model performance. Healthcare AI has entered a prove-it phase. Safety-Aware ROC offers a practical framework for rule-in, rule-out and gray-zone deployment decisions, and a Kenya-based LLM trial tested AI inside real clinician workflows. Philips' Future Health Index shows measurable AI gains but inconsistent clinician training.
Governance gaps around data. Weak BAAs, broad data rights and unclear AI supply chains are becoming deal blockers. Recent breaches show accountability cannot be outsourced when systems act on patient data, and AI agents need oversight similar to human teams. In dental AI, liability remains a gray zone where clinicians are accountable whether they follow or override the AI.
Into new specialties and cheaper alternatives. Medtronic's Hugo RAS is expanding into general and gynecologic surgery, and DaVinci5 activity points to renewed momentum for cardiac robotic surgery in Europe. Intellijoint KNEE offers imageless, tablet-based AI navigation as a lower-capital option. Economics are judged by episode cost, recovery time and productivity.
How we solve real problems for real clients